back to 2004, vol. 10, b. 1
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2004, vol. 10, book 1
Subject Collection: Medicine
Page: 38-41
DOI: 10.5272/jimab.2004101.38
Online date: October 19, 2004

J of IMAB 2004; 10(1):38-41
Ani Tsvetanova1, Dimitar Gospodinov1, Miroslav Donchev2
1) Department of Dermatology and Venereology, 2) Clinical center of nuclear medicine, Medical University, Pleven, Bulgaria

Androgenetic alopecia (AA) is considered as a genetically determinate androgen (DHT)-dependent disorder. Theoretically Dehydroepyandrosterone-sulfate (DHEA-S) is the first main metabolite in the androgen metabolism.
The aim of the study was to determine the serum-levels of DHEA-S (DHEA-S(s)) in patients with AA and the possible correlation between clinical stage of AA and DHEA-S(s).
Forty-four men (37 with male pattern baldness and 7 healthy controls) aged 19 to 55 had DHEA-S(s) measured. Determination of the hormone was performed by standard radioimmunoassay. Only nine of the men with AA showed high levels of DHEA-S(s). In 3 of the patients were detected a boundary high levels of DHEA-S(s). No correlation between the clinical stage of AA and DHEA-S(s) -levels was established. There was relationship only between increase of the age and decrease of the concentrations of DHEA-S(s).
In contrast to previous studies, in our investigation, no elevation of DHEA-S(s) in men with AA was found. Our results indirect support the current understanding of the importance of some follicular enzymes (STS, 3-beta-HSD, 17-beta-HSD etc.) that could increase the amount of the alternative DHT-sources in AA, as well as the theory for the “endocrinology of hair follicle”.

Key words: androgenetic alopecia, male pattern baldness, serum-levels of DHEA-S.

- Download FULL TEXT (PDF - 262 KB)
Please cite this article as: Tsvetanova A, Gospodinov D, Donchev M. SERUM-CONCENTRATIONS OF Dehydroepyandrosterone-sulfate IN MEN WITH ANDROGENETIC ALOPECIA. J of IMAB. 2004; 10(1):38-41; DOI: 10.5272/jimab.2004101.38

1. Alesci S, Bornstein SR. Neuroimmunoregulation of androgens in the adrenal gland and the skin. Horm Res 2000; 54(5-6): 281-286
2. Andersson S. Steroidogenic enzymes in skin. Eur J Dermatol 2001; 11: 293-295
3. Bayne EK et al. Immunohistochemical localization of types 1 and 2 5a-reductase in human scalp. Br J Dermatol 1999;141: 481-491
4. Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol 2002; 119(5): 992-1007
5. Choi MH, Yoo YS, Chung BC. Biochemical Roles of Testosterone and Epitestosterone to 5-Reductase as Indicators of Male-Pattern Baldness.  J Invets Dermatol 2001; 116 (1): 57-61
6. Deplewski D, Rosenfield R.L. Role of Hormones in Pilosebaceous Unit Development. Endocrine Reviews 2000; 21: 363–392
7. Hoffmann R, Happle R. Current understanding of Androgenetic Alopecia, Part I: Etiopathogenesis. Eur J Dermatol 2000; 10: 319-326
8. Hoffmann R. Enzymology of the hair follicle. Eur J Dermatol 2001;11(4): 296-300
9. Hoffmann R, Rot A, Niiyama S, Billich A. Steroid Sulfatase in the Human Hair Follicle Concentrates in the Dermal Papilla.  J Invest Dermatol 2001; 117: 1342-1348
10. Hoffmann R. Interaction hormonale et croissance du cheveu. Ann Dermatol Venereol 2002; 129: 787-792
11. Kuester W, Happle R. The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 1984;11: 921-926
12. Labrie F. Intracrinology. Mol Cell Endocrinol. 1991;78(3): C113-118
13. Labrie F et al. Intracrinology: role of the family of 17beta hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol 2000; 25: 1-16
14. Nitsche EM, Hiort O. The molecular basis of androgen insensitivity. Horm Res 2000; 54(5-6): 327-333
15. Norwood OT. Male pattern baldness: classification and icidence South Med J.1975; 68(11): 1359-1365
16. Pitts RL. Serum elevation of dehidroepiandrosterone sulfate associated with male pattern baldness in young men. J Am Acad dermatol 1987; 16: 571-573
17. Randall VA et al. The hair follicle: a paradoxical androgen target organ. Horm Res 2000; 54 (5-6): 243-250
18. Sawaya ME, Price V.H. Different levels of 5a-reductase type I and II, aromatase and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997; 109 (3): 296-300
19. Schell H, Kieswetter F, Langer P, Hintzenstern J. v. Zellkinetik epilierter Kopfhaare und Plasma- Androgene bei Maennern mit androgenetischer Alopezie. Z hautkr 1991; 66(7): 575-578
20. Schmidt JB, Lindmeier A, Spona J. Hormonal parameters in Androgenetic Hair Loss in the men. Dermatologica 1991; 182: 214-217
21. Van Steensel MAM, Van Geel M, Steijlen PM. The molecular basis of hair growth. European J Dermatol 2001; 11: 348-352
22. Vogt A, Blume-Peytavi U. Biology of the human hair follicle. New knowledge and the clinical significance. Hautarzt 2003;54(8): 692-698
23. Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res 2000; 54(5-6): 230-242

back to Online Journal